SIGMAR1 and COVID-19: Furthermore, Sig-1R ligands like haloperidol, an antipsychotic, have appeared in screens of COVID-19 therapy and fibrosis aimed at repurposing approved drugs or drugs in clinical development, an advantageous approach to reduce the times required for de novo drug discovery.